Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnexa M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Bionexa Organic

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimnexa M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with a readily available fast-acting sugar source (e.g., glucose tablets, juice). Alcohol consumption elevates hypoglycemia risk and should be minimized. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a potential side effect. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Use during pregnancy or breastfeeding necessitates prior medical consultation. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimnexa M 1mg/500mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Glimnexa M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimnexa M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimnexa M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimnexa M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnexa M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glimnexa M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Glimnexa M 1mg/500mg Tablet works:

Glimnexa M tablets (1mg/500mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimnexa M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnexa M 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingUNSAFE

Lactation and Glimnexa M 1mg/500mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimnexa M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimnexa M 1mg/500mg tablets. Physician consultation is essential. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimnexa M 1mg/500mg tablets cautiously. Dosage modifications may be necessary. Medical advice is recommended. For those with mild to moderate liver disease, Glimnexa M 1mg/500mg tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimnexa M 1mg/500mg Tablet :

Should you forget a Glimnexa M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnexa M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimnexa M 1mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent accidental ingestion by children, pets, and others.
Glimnexa M 1mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly risky for individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimnexa M 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and metformin, combined as Glimnexa M 1mg/500mg tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a balanced diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin decreases hepatic glucose production and improves cellular insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes.
Glimnexa M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Indeed, prolonged Glimnexa M 1mg/500mg Tablet consumption can lead to Vitamin B12 deficiency. This medication hinders Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications, such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic annual Vitamin B12 supplementation is recommended by some to mitigate these risks.
Glimnexa M 1mg/500mg Tablets may induce hypoglycemia (low blood glucose). Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimnexa M 1mg/500mg tablets and alcohol is unsafe. Alcohol consumption may exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia. Furthermore, it raises the risk of lactic acidosis.
Glimnexa M 1mg/500mg Tabl...
43
MRP 53
18% off